Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo

Objective(s): Breast cancer is one of the most common cancers among women, and current treatments are inadequate due to unwarranted side effects and lack of specificity resulting in off target consequences. Artesunate is a synthetic anti-malarial drug that exerts inhibitory effects on cancer cell li...

Full description

Saved in:
Bibliographic Details
Main Authors: Amirreza Safdarian, Massoumeh Ebtekar, zouhair Mohammad Hassan, Hossein Naderi Manesh, Hashemi Seyed Ali, Saeed Samaeinasab, Danial Habibi, Hossein Khorramdelazad
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2024-10-01
Series:Nanomedicine Journal
Subjects:
Online Access:https://nmj.mums.ac.ir/article_24770_c886dbd0f6fa74baf6fa735ec993f01c.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849420124417687552
author Amirreza Safdarian
Massoumeh Ebtekar
zouhair Mohammad Hassan
Hossein Naderi Manesh
Hashemi Seyed Ali
Saeed Samaeinasab
Danial Habibi
Hossein Khorramdelazad
author_facet Amirreza Safdarian
Massoumeh Ebtekar
zouhair Mohammad Hassan
Hossein Naderi Manesh
Hashemi Seyed Ali
Saeed Samaeinasab
Danial Habibi
Hossein Khorramdelazad
author_sort Amirreza Safdarian
collection DOAJ
description Objective(s): Breast cancer is one of the most common cancers among women, and current treatments are inadequate due to unwarranted side effects and lack of specificity resulting in off target consequences. Artesunate is a synthetic anti-malarial drug that exerts inhibitory effects on cancer cell lines via apoptosis and has been used treating some cancers. This study investigated the anticancer effects of Fe3O4 magnetic nanoparticles conjugated with chitosan, polyethylene glycol, folic acid, and artesunate in vivo and in vitro.Materials and Methods: Nanoparticles were synthesized by co-precipitation; morphology and size were determined by scanning electron microscopy (SEM), and the presence of the components was verified by nanoscale Fourier transform infrared spectroscopy (FTIR).  4T1 murine mammary tumor cells were treated with nanoparticles, and cell viability was determined by MTT assay. 4T1 cells were also subcutaneously injected into BALB/c mice, and magnetic resonance imaging was carried out two weeks later to determine tumor size among the groups.  Interferon gamma (IFN-γ) and IL-4 levels (in splenocytes culture supernatant) were measured by ELISA, and tumors, surrounding tissues, and mouse livers were histopathologically studied. Results: The nanoparticle made in this article had good anticancer effects and caused apoptosis in cancer cells in breast cancer, and also strengthened the cellular immune system and further increased interferon gamma and increased the half-life of mice with cancer, while this nanoparticle It did not have the side effects of chemotherapy drugs.Conclusion: Artesunate-containing nanoparticles decreased 4T1 cell viability and increased apoptosis to a greater extent than nanoparticles without the drug. In vivo, artesunate nanoparticles showed no toxicity and were more effective in decreasing tumor size than control. They were also associated with increased survival, increased IFN-γ, and decreased IL-4 levels in the spleen. The findings show the drug targets cancer  cells effectively with minimal side effects due to its herbal nature and targeted nano delivery.
format Article
id doaj-art-137df80778954be38a6e8dfc40f2ecde
institution Kabale University
issn 2322-3049
2322-5904
language English
publishDate 2024-10-01
publisher Mashhad University of Medical Sciences
record_format Article
series Nanomedicine Journal
spelling doaj-art-137df80778954be38a6e8dfc40f2ecde2025-08-20T03:31:51ZengMashhad University of Medical SciencesNanomedicine Journal2322-30492322-59042024-10-0111436837710.22038/nmj.2024.76265.186424770Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivoAmirreza Safdarian0Massoumeh Ebtekar1zouhair Mohammad Hassan2Hossein Naderi Manesh3Hashemi Seyed Ali4Saeed Samaeinasab5Danial Habibi6Hossein Khorramdelazad7Department of Immunology, Faculty of Medicine, Tarbiat Modares University, Tehran, IranDepartment of Immunology, Faculty of Medicine, Tarbiat Modares University, Tehran, IranDepartment of Immunology, Faculty of Medicine, Tarbiat Modares University, Tehran, IranDepartment of Biophysics, Nanobiotechnology Faculty of Biological Sciences Tarbiat Modares UniversityTehran, IranDepartment of Pathology, School of Medicine, Alborz University of Medical Sciences, Karaj,IranImmunology Board for Transplantation and Cell-Based Therapeutics (Immuno_TACT), Universal Scientific Education and Research Network (USERN), Tehran, IranDepartment of Biostatistics and Epidemiology, School of Public Health, Babol University of Medical Sciences, Babol, IranDepartment of Immunology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, IranObjective(s): Breast cancer is one of the most common cancers among women, and current treatments are inadequate due to unwarranted side effects and lack of specificity resulting in off target consequences. Artesunate is a synthetic anti-malarial drug that exerts inhibitory effects on cancer cell lines via apoptosis and has been used treating some cancers. This study investigated the anticancer effects of Fe3O4 magnetic nanoparticles conjugated with chitosan, polyethylene glycol, folic acid, and artesunate in vivo and in vitro.Materials and Methods: Nanoparticles were synthesized by co-precipitation; morphology and size were determined by scanning electron microscopy (SEM), and the presence of the components was verified by nanoscale Fourier transform infrared spectroscopy (FTIR).  4T1 murine mammary tumor cells were treated with nanoparticles, and cell viability was determined by MTT assay. 4T1 cells were also subcutaneously injected into BALB/c mice, and magnetic resonance imaging was carried out two weeks later to determine tumor size among the groups.  Interferon gamma (IFN-γ) and IL-4 levels (in splenocytes culture supernatant) were measured by ELISA, and tumors, surrounding tissues, and mouse livers were histopathologically studied. Results: The nanoparticle made in this article had good anticancer effects and caused apoptosis in cancer cells in breast cancer, and also strengthened the cellular immune system and further increased interferon gamma and increased the half-life of mice with cancer, while this nanoparticle It did not have the side effects of chemotherapy drugs.Conclusion: Artesunate-containing nanoparticles decreased 4T1 cell viability and increased apoptosis to a greater extent than nanoparticles without the drug. In vivo, artesunate nanoparticles showed no toxicity and were more effective in decreasing tumor size than control. They were also associated with increased survival, increased IFN-γ, and decreased IL-4 levels in the spleen. The findings show the drug targets cancer  cells effectively with minimal side effects due to its herbal nature and targeted nano delivery.https://nmj.mums.ac.ir/article_24770_c886dbd0f6fa74baf6fa735ec993f01c.pdfbreast cancercancer therapydrug deliverynanoparticle
spellingShingle Amirreza Safdarian
Massoumeh Ebtekar
zouhair Mohammad Hassan
Hossein Naderi Manesh
Hashemi Seyed Ali
Saeed Samaeinasab
Danial Habibi
Hossein Khorramdelazad
Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo
Nanomedicine Journal
breast cancer
cancer therapy
drug delivery
nanoparticle
title Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo
title_full Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo
title_fullStr Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo
title_full_unstemmed Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo
title_short Artesunate-loaded Fe3O4 nanoparticles: A novel approach for combating 4T1 breast cancer cells in vitro and in vivo
title_sort artesunate loaded fe3o4 nanoparticles a novel approach for combating 4t1 breast cancer cells in vitro and in vivo
topic breast cancer
cancer therapy
drug delivery
nanoparticle
url https://nmj.mums.ac.ir/article_24770_c886dbd0f6fa74baf6fa735ec993f01c.pdf
work_keys_str_mv AT amirrezasafdarian artesunateloadedfe3o4nanoparticlesanovelapproachforcombating4t1breastcancercellsinvitroandinvivo
AT massoumehebtekar artesunateloadedfe3o4nanoparticlesanovelapproachforcombating4t1breastcancercellsinvitroandinvivo
AT zouhairmohammadhassan artesunateloadedfe3o4nanoparticlesanovelapproachforcombating4t1breastcancercellsinvitroandinvivo
AT hosseinnaderimanesh artesunateloadedfe3o4nanoparticlesanovelapproachforcombating4t1breastcancercellsinvitroandinvivo
AT hashemiseyedali artesunateloadedfe3o4nanoparticlesanovelapproachforcombating4t1breastcancercellsinvitroandinvivo
AT saeedsamaeinasab artesunateloadedfe3o4nanoparticlesanovelapproachforcombating4t1breastcancercellsinvitroandinvivo
AT danialhabibi artesunateloadedfe3o4nanoparticlesanovelapproachforcombating4t1breastcancercellsinvitroandinvivo
AT hosseinkhorramdelazad artesunateloadedfe3o4nanoparticlesanovelapproachforcombating4t1breastcancercellsinvitroandinvivo